Evidence map›Paper›PMID 32901980›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

Perfluorobutane sulfonate exposure disrupted human placental cytotrophoblast cell proliferation and invasion involving in dysregulating preeclampsia related genes.

William P Marinello, Zahra S Mohseni, Sarah J Cunningham, Christine Crute, Rong Huang, Jun J Zhang, Liping Feng

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

William P MarinelloDepartment of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC, USA.
Zahra S MohseniDepartment of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC, USA.
Sarah J CunninghamUniversity Program in Genetics and Genomics, Duke University, Durham, NC, USA.
Christine CruteDepartment of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC, USA.
Rong HuangMOE-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Jiao Tong University School of Medicine, Shanghai, China.
Jun J ZhangMOE-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Jiao Tong University School of Medicine, Shanghai, China.
Liping FengDepartment of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC, USA.
Duke University · USShanghai Children's Hospital · CNXinHua Hospital · CN

Funding

Duke University Program in Environmental HealthT32ES021432 · NIEHS · DUKE UNIVERSITY · PI Akhenaton-Andrew Dhafir Jones, Joel Newman Meyer · 2013 to 2026
$4.0M
Effects of perfluorobutane sulfonate (PFBS) exposure on adverse pregnancy outcomes and fetal developmentK01TW010828 · FIC · DUKE UNIVERSITY · PI FENG, LIPING · 2017 to 2021
$523k
FIC NIH HHS K01 TW010828HHS | National Institutes of Health (NIH) 1K01TW010828-01NIEHS NIH HHS T32 ES021432
6 · The paper itself

Abstract

We reported that maternal PFBS, an emerging pollutant, exposure is positively associated with preeclampsia which can result from aberrant trophoblasts invasion and subsequent placental ischemia. In this study, we investigated the effects of PFBS on trophoblasts proliferation/invasion and signaling pathways. We exposed a human trophoblast line, HTR8/SVneo, to PFBS. Cell viability, proliferation, and cell cycle were evaluated by the MTS assay, Ki-67 staining, and flow cytometry, respectively. We assessed cell migration and invasion with live-cell imaging-based migration assay and matrigel invasion assay, respectively. Signaling pathways were examined by Western blot, RNA-seq, and qPCR. PFBS exposure interrupted cell proliferation and invasion in a dose-dependent manner. PFBS (100 μM) did not cause cell death but instead significant cell proliferation without cell cycle disruption. PFBS (10 and 100 μM) decreased cell migration and invasion, while PFBS (0.1 μM) significantly increased cell invasion but not migration. Further, RNA-seq analysis identified dysregulated HIF-1α target genes that are relevant to cell proliferation/invasion and preeclampsia, while Western Blot data showed the activation of HIF-1α, but not Notch, ERK1/2, (PI3K)AKT, and P38 pathways. PBFS exposure altered trophoblast cell proliferation/invasion which might be mediated by preeclampsia-related genes, suggesting a possible association between prenatal PFBS exposure and adverse placentation.

Indexed as

Cell ProliferationApoptosisCell CycleCell MovementCells, CulturedFemaleFluorocarbonsGene Expression ProfilingGene Expression RegulationHumansMitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesPlacentaPre-EclampsiaPregnancyProto-Oncogene Proteins c-aktFluorocarbonsMitogen-Activated Protein Kinasesperfluorobutanesulfonic acidPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSulfonic AcidsinvasionPFBSplacenta cytotrophoblastpreeclampsiaproliferation

Identifiers

PMID32901980
PMCPMC9012146
OpenAlexW3083785313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.